CoChat

Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19

Open access
Tejerina, Francisco, Catalan, Pilar, Rodriguez-Grande, Cristina, Adan, Javier, Rodriguez-Gonzalez, Carmen, Muñoz, Patricia, Aldamiz, Teresa, Diez, Cristina, Perez, Leire, Fanciulli, Chiara, Garcia de Viedma, Dario, Gregorio Marañon Microbiology ID COVID 19 Study Group, Alcalá, Luis, Alonso, Roberto, Álvarez, Beatriz, Álvarez-Uría, Ana, Arias, Alexi, Arroyo, Luis Antonio, Berenguer, Juan, Bermúdez, Elena, Bouza, Emilio, Burillo, Almudena, Candela, Ana, Carrillo, Raquel, Cercenado, Emilia, Cobos, Alejandro, Escribano, Pilar, Estévez, Agustín, Fernandez, Silvia, Galar, Alicia, García, Mª Dolores, Gijón, Paloma, González, Adolfo, Guillén, Helmuth, Guinea, Jesús, Haces, Laura Vanessa, Kestler, Martha, López, Juan Carlos, Losada, Carmen Narcisa, Machado, Marina, Marín, Mercedes, Martín, Pablo, Martín, Paloma, Montilla, Pedro, Moure, Zaira, Muñoz, Patricia, Olmedo, María, Padilla, Belén, Palomo, María, Parras, Francisco, Pérez-Granda, María Jesús, Pérez, Laura, Pescador, Paula, Reigadas, Elena, Rincón, Cristina, Rodríguez, Belén, Rodríguez, Sara, Rojas, Adriana, Ruiz-Serrano, María Jesús, Sánchez, Carlos, Sánchez, Mar, Serrano, Julia, Valerio, Maricela, Veintimilla, Mª Cristina, Vesperinas, Lara, Vicente, Teresa, de la Villa, Sofía · 2022 · BMC Infectious Diseases
Cited by 131

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Background: There is a paucity of knowledge on the long-term outcome in patients diagnosed with COVID-19. We describe a cohort of patients with a constellation of symptoms occurring four weeks after diagnosis causing different degrees of reduced functional capacity. Although different hypothesis have been proposed to explain this condition like persistent immune activation or immunological dysfunction, to date, no physiopathological mechanism has been identified. Consequently, there are no therapeutic options besides symptomatic treatment and rehabilitation. Methods: We evaluated patients with symptoms that persisted for at least 4 weeks after COVID-19. Epidemiological and clinical data were collected. Blood tests, including inflammatory markers, were conducted, and imaging studies made if deemed necessary. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcription polymerase chain reaction (RT-PCR) in plasma, stool, and urine were performed. Patients were offered antiviral treatment (compassionate use). Results: We evaluated 29 patients who reported fatigue, muscle pain, dyspnea, inappropriate tachycardia, and low-grade fever. Median number of days from COVID-19 to positive RT-PCR in extra-respiratory samples was 55 (39–67). Previous COVID-19 was mild in 55% of the cases. Thirteen patients (45%) had positive plasma RT-PCR results and 51% were positive in at least one RT-PCR sample (plasma, urine, or stool). Functional status was severely reduced in 48% of the subjects. Eighteen patients (62%) received antiviral treatment. Improvement was seen in most patients (p = 0.000) and patients in the treatment group achieved better outcomes with significant differences (p = 0.01). Conclusions: In a cohort of COVID-19 patients with persistent symptoms, 45% of them have detectable plasma SARS-CoV-2 RNA. Our results indicate possible systemic viral persistence in these patients, who may benefit of antiviral treatment strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12879-022-07153-4

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 131

Metadata

Authors
Tejerina, F., Catalan, P., Rodriguez-Grande, C., Adan, J., Rodriguez-Gonzalez, C., Muñoz, P., Aldamiz, T., Diez, C., Perez, L., Fanciulli, C., Garcia de Viedma, D., Gregorio Marañon Microbiology ID COVID 19 Study Group, Alcalá, L., Alonso, R., Álvarez, B., Álvarez-Uría, A., Arias, A., Arroyo, L. A., Berenguer, J., Bermúdez, E., Bouza, E., Burillo, A., Candela, A., Carrillo, R., Cercenado, E., Cobos, A., Escribano, P., Estévez, A., Fernandez, S., Galar, A., García, M. D., Gijón, P., González, A., Guillén, H., Guinea, J., Haces, L. V., Kestler, M., López, J. C., Losada, C. N., Machado, M., Marín, M., Martín, P., Martín, P., Montilla, P., Moure, Z., Muñoz, P., Olmedo, M., Padilla, B., Palomo, M., Parras, F., Pérez-Granda, M. J., Pérez, L., Pescador, P., Reigadas, E., Rincón, C., Rodríguez, B., Rodríguez, S., Rojas, A., Ruiz-Serrano, M. J., Sánchez, C., Sánchez, M., Serrano, J., Valerio, M., Veintimilla, M. C., Vesperinas, L., Vicente, T., & de la Villa, S.
Venue
BMC Infectious Diseases
Published
2022-03-03
Volume
22
Issue
1
Pages
211-211
ISSN
1471-2334 (ISSN-L)
OpenAlex
W4214951573
Cited by
131
References
7
FWCI
14.15
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. https://app.cochat.ai/papers/10.1186/s12879-022-07153-4
The paper
Tejerina, F., Catalan, P., Rodriguez-Grande, C., Adan, J., Rodriguez-Gonzalez, C., Muñoz, P., Aldamiz, T., Diez, C., Perez, L., Fanciulli, C., Garcia de Viedma, D., Gregorio Marañon Microbiology ID COVID 19 Study Group, Alcalá, L., Alonso, R., Álvarez, B., Álvarez-Uría, A., Arias, A., Arroyo, L. A., Berenguer, J., . . . de la Villa, S. (2022). Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infectious Diseases. https://doi.org/10.1186/s12879-022-07153-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.